长链非编码RNA AK146527通过靶向miR-15/16调控骨形成的分子机制OA
Molecular mechanism of long non coding RNA AK146527 regulating bone formation by targeting miR-15/16
目的:检测AK146527对成骨分化和骨形成的调控作用;研究AK146527靶向miR-15/16促进骨形成的分子机制,并探究AK146527功能区的原位促成骨作用.方法:利用RT-PCR检测小鼠股骨组织中AK146527表达水平和骨形成标志因子的相关性;在MC3T3-E1前成骨细胞中转染AK146527的过表达质粒和siRNA检测AK146527对成骨细胞分化的作用;对转染AK146527后MC3T3-E1前成骨细胞中的成骨分化关键转录因子的活性进行了初步筛选,检测AK146527对成骨分化调控的具体信号通路;用AK146527的过表达质粒或siRNA转染MC3T3-E1细胞,并检测转染后细胞中miR-15/16家族的水平,研究其对miR-15/16家族的靶向调控作用;在MC3T3-E1细胞和C57BL/6小鼠中转染了 AK146527不同区域过表达质粒,并检测转染后细胞成骨分化水平和小鼠骨形成水平,证明AK146527与miR-15/16的结合序列可以调控成骨细胞分化和骨形成;构建了去卵巢OP小鼠模型,并在小鼠颅骨皮下局部转染了 AK146527结合区过表达质粒,研究AK146527结合区对OP的治疗效果;最后,通过类器官技术证明了 AK146527结合区的原位促成骨效果.结果:(1)AK146527表达水平与骨形成相关;(2)AK146527可促进骨形成;(3)AK146527对成骨分化的调控可能是基于wnt信号通路;(4)AK146527可通过其结合区域结合miR-15/16家族,从而起到抑制作用,具有专一性;(5)AK146527通过miR-15/16结合位点调控成骨分化;(6)AK146527结合区具有原位促成骨作用,在骨缺损修复中表现出良好的应用潜力.结论:AK146527与骨形成高度相关,并可通过靶向miR-15/16促进成骨分化和骨形成.其与miR-15/16结合区可以对去卵巢骨质疏松小鼠的骨形成有恢复效果.此外AK146527功能区在颅骨缺损小鼠植入类器官后具有原位促成骨和原位骨修复的效果.本研究对骨形成的机制研究提供了新的理论和实验基础,并为提高骨形成相关LncRNA的调控效率提供了新策略.
Objective:To investigate the regulatory role of AK146527 in osteogenic differentiation and bone formation,explore the molecular mechanism by which AK146527 promotes bone formation through targeting miR-15/16,and assess the in situ osteogenic effect of the functional region of AK146527.Methods:RT-PCR was performed to detect the expression levels of AK146527 in mouse femoral tissues,and the correlation between AK146527 expression and bone formation markers was analyzed.MC3T3-E1 pre-osteoblasts were transfected with AK146527 overexpression plasmids or siRNA to evaluate the effect of AK146527 on osteoblast differentiation.The activity of key transcription factors involved in osteogenic differentiation was preliminarily screened in MC3T3-E1 cells after AK146527 transfection to explore the specific signaling pathways through which AK146527 regulates osteogenic differentiation.MC3T3-E1 cells were transfected with AK146527 overexpression plasmids or siRNA,and the levels of miR-15/16 family members were measured to investigate the targeted regulation of the miR-15/16 family by AK146527.MC3T3-E1 cells and C57BL/6 mice were transfected with overexpression plasmids targeting different regions of AK146527,and osteogenic differentiation levels in cells and bone formation levels in mice were assessed to confirm that the binding sequence of AK146527 with miR-15/16 regulates osteoblast differentiation and bone formation.An ovariectomized(OP)mouse model was established,and overexpression plasmids containing the AK146527 binding region were locally transfected into the subcutis of the mouse skull to evaluate the therapeutic effect of the AK146527 binding region on OP.Finally,the in situ osteogenic effect of the AK146527 binding region was validated using organoid technology.Results:The expression level of AK146527 was correlated with bone formation.AK146527 promoted bone formation.The regulatory effect of AK146527 on osteogenic differentiation may involve the Wnt signaling pathway.AK146527 specifically bound to and inhibited the miR-15/16 family through its binding region.AK146527 regulated osteogenic differentiation via the miR-15/16 binding site.The binding region of AK146527 exhibited in situ osteogenic effects and demonstrated promising potential for application in bone defect repair.Conclusion:AK146527 is highly correlated with bone formation and promotes osteogenic differentiation and bone formation by targeting miR-15/16.Its binding region with miR-15/16 can restore bone formation in ovariectomized osteoporotic mice.Additionally,the functional region of AK146527 exhibits in situ osteogenic and bone repair effects after implantation into organoids in a mouse skull defect model.This study provides a novel theoretical and experimental foundation for understanding the mechanisms of bone formation and offers a new strategy to enhance the regulatory efficiency of bone formation-related LncRNAs.
禹欣池;于瑾舒;焦丽;梁骑;印崇
川北医学院检验医学院转化医学研究中心,四川南充 637000川北医学院检验医学院转化医学研究中心,四川南充 637000中国医学科学院医学生物学研究所,云南 昆明 650000川北医学院检验医学院转化医学研究中心,四川南充 637000||川北医学院附属医院检验科,四川南充 637000川北医学院检验医学院转化医学研究中心,四川南充 637000||川北医学院附属医院检验科,四川南充 637000
医药卫生
长链非编码RNA成骨细胞分化miRNA骨形成
Long non-coding RNAOsteoblast differentiationmiRNABone formation
《川北医学院学报》 2026 (3)
267-277,11
国家自然科学基金(82101640)四川省自然科学基金项目(23NSFSC6012)四川省卫健委项目(21PJ101)
评论